Evidence map›Paper›PMID 30498625›Full record

ReviewAmerican journal of clinical and experimental immunology2018

Treatment of multiple system atrophy - the past, present and future.

Haiyan Yu, Xiaoling Yuan, Lifeng Liu, Tian Wang, Dianrong Gong

Open access · greenAbstract readReview
PubMed Full text at PMC
In one paragraph

Review in American journal of clinical and experimental immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Haiyan YuDepartment of Neurology, Liaocheng People's Hospital, Liaocheng Clinical School, Taishan Medical University Liaocheng, PR China.
Xiaoling YuanDepartment of Neurology, Liaocheng People's Hospital, Liaocheng Clinical School, Taishan Medical University Liaocheng, PR China.
Lifeng LiuDepartment of Neurology, Liaocheng People's Hospital, Liaocheng Clinical School, Taishan Medical University Liaocheng, PR China.
Tian WangTaishan Medical University Liaocheng, PR China.
Dianrong GongDepartment of Neurology, Liaocheng People's Hospital, Liaocheng Clinical School, Taishan Medical University Liaocheng, PR China.
Liaocheng People's Hospital · CNLiaocheng University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple system atrophy is a sporadic progressive degenerative disease which is characterized by multiple central nervous systems involved. So far, there is no effective medicine to cure MSA. The main research direction of treatment includes immunization transplantation and cytotherapy. Human umbilical cord blood is the residue of blood in the placenta and umbilical cord after fetal delivery. It is the most abundant cell bank and its usage is not limited to treat hematological diseases. The researches about hUCB-MNC treatment on MSA are increasing gradually. The potential of other MSC is also discussed. Lateral atlanto-occipital space puncture is an ingenious way created by Professor Dianrong Gong. More than 30 cases of MSA have been treated by this method with fine clinical effect and without serious complications. It indicates that stem cells treatment is a valid method for refractory nerve system diseases.

Indexed as

human umbilical cord blood-mononuclear celllateral atlanto-occipital space punctureMultiple system atrophystem cells

Identifiers

PMID30498625
PMCPMC6261842
OpenAlexW2981400372

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.